Oppenheimer & Co’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,910
| Closed | -$150K | – | 1667 |
|
|
2025
Q1 | $150K | Hold |
16,910
| – | – | ﹤0.01% | 1488 |
|
|
2024
Q4 | $232K | Sell |
16,910
-1,156
| -6% | -$15.8K | ﹤0.01% | 1395 |
|
|
2024
Q3 | $495K | Hold |
18,066
| – | – | 0.01% | 1032 |
|
|
2024
Q2 | $442K | Buy |
18,066
+2,878
| +19% | +$70.4K | 0.01% | 1040 |
|
|
2024
Q1 | $324K | Hold |
15,188
| – | – | 0.01% | 1151 |
|
|
2023
Q4 | $291K | Sell |
15,188
-441
| -3% | -$8.44K | 0.01% | 1154 |
|
|
2023
Q3 | $251K | Sell |
15,629
-9
| -0.1% | -$144 | 0.01% | 1189 |
|
|
2023
Q2 | $362K | Sell |
15,638
-42
| -0.3% | -$974 | 0.01% | 1093 |
|
|
2023
Q1 | $364K | Buy |
+15,680
| New | +$364K | 0.01% | 1068 |
|
|
2017
Q4 | – | Sell |
-40,850
| Closed | -$1.48M | – | 1341 |
|
|
2017
Q3 | $1.48M | Sell |
40,850
-250
| -0.6% | -$9.05K | 0.04% | 473 |
|
|
2017
Q2 | $1.06M | Sell |
41,100
-3,650
| -8% | -$94.3K | 0.03% | 578 |
|
|
2017
Q1 | $859K | Buy |
44,750
+8,900
| +25% | +$171K | 0.02% | 629 |
|
|
2016
Q4 | $598K | Buy |
+35,850
| New | +$598K | 0.02% | 747 |
|
|
2015
Q4 | – | Sell |
-12,401
| Closed | -$465K | – | 1339 |
|
|
2015
Q3 | $465K | Sell |
12,401
-350
| -3% | -$13.1K | 0.01% | 833 |
|
|
2015
Q2 | $433K | Sell |
12,751
-700
| -5% | -$23.8K | 0.01% | 947 |
|
|
2015
Q1 | $476K | Sell |
13,451
-150
| -1% | -$5.31K | 0.01% | 887 |
|
|
2014
Q4 | $463K | Sell |
13,601
-3,836
| -22% | -$131K | 0.01% | 856 |
|
|
2014
Q3 | $673K | Sell |
17,437
-17,069
| -49% | -$659K | 0.02% | 742 |
|
|
2014
Q2 | $1.34M | Buy |
34,506
+2,396
| +7% | +$93.3K | 0.04% | 511 |
|
|
2014
Q1 | $1.1M | Sell |
32,110
-1,878
| -6% | -$64.2K | 0.03% | 565 |
|
|
2013
Q4 | $713K | Buy |
33,988
+24,413
| +255% | +$512K | 0.02% | 693 |
|
|
2013
Q3 | $225K | Buy |
+9,575
| New | +$225K | 0.01% | 1100 |
|